PANVAC™-VF: poxviral-based vaccine therapy targeting CEA and MUC1 in carcinoma

By Madan Ravi A   Arlen Philip M   Gulley James L  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 4, 2007-04 ,pp. : 543-554

Informa Healthcare

Access to resources Recommend Favorite

Targeted Therapy of Respiratory Syncytial Virus by 2_5A Antisense

By Cramer Hagen   Okicki James   Kuang Mei   Xu Zan  

Nucleosides, Nucleotides & Nucleic Acids, Vol. 24, Iss. 5-7, 2005-04 ,pp. : 497-501

Taylor & Francis Ltd

Access to resources Recommend Favorite

Immunological monitoring of cancer vaccine therapy

By Nagorsen Dirk   Scheibenbogen Carmen   Thiel Eckhard   Keilholz Ulrich  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 10, 2004-10 ,pp. : 1677-1684

Informa Healthcare

Access to resources Recommend Favorite

Vascular-targeted cancer gene therapy

By Dougherty Graeme J   Davis Peter D   Dougherty Shona T  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 12, 2004-12 ,pp. : 1911-1920

Informa Healthcare

Access to resources Recommend Favorite

Gene therapy as a vaccine for HIV-1

By Berkhout Ben   Sanders Rogier W  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 10, 2012-10 ,pp. : 1315-1321

Informa Healthcare

Access to resources Recommend Favorite